Human Intrahepatic Cholangiocarcinoma Organoid is a 3D cancer model derived from intrahepatic cholangiocarcinoma (iCCA) tumor tissues. These organoids closely replicate the structural and molecular characteristics of the original tumor, including cholangiocyte differentiation and tumor microenvironment interactions. This organoid model offers a reliable platform for studying cholangiocarcinoma progression, tumor biology, and drug screening. It allows researchers to better understand intrahepatic cholangiocarcinoma pathophysiology and evaluate potential therapeutic options in a more clinically relevant setting compared to traditional 2D cell cultures. The organoids undergo rigorous testing for mycoplasma, bacteria, fungi/yeast, and are validated for identity, genetic stability, and functional performance.
Embedded 3D Culture
All test negative for mycoplasma, bacteria, yeast, and fungi.
For research use only. Tissue-derived organoids are widely used in drug screening, disease modeling, mechanism research, personalized medicine, and regenerative medicine. By simulating authentic disease states, these organoids provide an ideal platform to assess patient responses to new drugs and assist in the design of personalized treatment plans. Additionally, they drive the development of new therapeutic approaches, particularly in cancer research and organ regeneration, offering precise experimental tools that greatly enhance the advancement of precision medicine.
Whether you're exploring disease mechanisms or screening novel therapeutics, OgCelix is your trusted partner.
Let's build the future of translational research together.
Whether you're exploring disease mechanisms or screening novel therapeutics, OgCelix is your trusted partner.
Let's build the future of translational research together.